-+ 0.00%
-+ 0.00%
-+ 0.00%

Kura Oncology's stock price fell 18.5% because Johnson & Johnson released data related to a hematologic cancer treatment.

Zhitongcaijing·11/04/2026 17:49:06
Listen to the news
Kura Oncology's stock price fell 18.5% because Johnson & Johnson released data related to a hematologic cancer treatment.